Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David J Gross

Showing results (51-60 of 74) with videos related to

Pageof 8
Sort By:
Chest|February 16, 2020
Somatostatin Analogs Improve Respiratory Symptoms in Patients With Diffuse Idiopathic Neuroendocrine Cell HyperplasiaTaymeyah Al-Toubah, Jonathan Strosberg, Thorvardur R Halfdanarson, et al.
European Journal of Endocrinology|July 30, 2008
Long-acting somatostatin analogues are an effective treatment for type 1 gastric carcinoid tumoursSimona Grozinsky-Glasberg, Gregory Kaltsas, Chamutal Gur, et al.
Academic Pathology|October 17, 2022
Features of burnout amongst pathologists: A reassessmentMichael B Cohen, Marisa Saint Martin, David J Gross, et al.
The Journal of Heart Valve Disease|December 19, 2016
Valve Replacement in Patients with Carcinoid Heart Disease: Choosing the Right Valve at the Right TimeAmit Korach, Simona Grozinsky-Glasberg, Joseph Atlan, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|May 12, 2020
The prognostic value of lymph node ratio in Medullary thyroid carcinoma: A multi-center studyTal Rozenblat, Dania Hirsch, Eyal Robenshtok, et al.
European Journal of Nuclear Medicine and Molecular Imaging|October 22, 2018
Highly favourable outcomes with peptide receptor radionuclide therapy (PRRT) for metastatic rectal neuroendocrine neoplasia (NEN)Grace Kong, Simona Grozinsky-Glasberg, Michael S Hofman, et al.
Archives of Pathology & Laboratory Medicine|July 1, 2022
Strong Job Market for Pathologists: Results From the 2021 College of American Pathologists Practice Leader SurveyDavid J Gross, Stanley J Robboy, Michael B Cohen, et al.
Clinical Nuclear Medicine|December 14, 2011
Ga-68 DOTA-NOC uptake in the pancreas: pathological and physiological patternsYodphat Krausz, Rina Rubinstein, Liat Appelbaum, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 29, 2021
Efficacy and Safety of <sup>177</sup>Lu-DOTATATE in Lung Neuroendocrine Tumors: A Bicenter studyLamiaa Zidan, Amir Iravani, Kira Oleinikov, et al.
Endocrine-Related Cancer|September 21, 2005
Etoposide, doxorubicin and cisplatin plus mitotane in the treatment of advanced adrenocortical carcinoma: a large prospective phase II trialAlfredo Berruti, Massimo Terzolo, Paola Sperone, et al.
Pageof 8

Showing results (51-60 of 74) with videos related to

Sort By:
Pageof 8
Chest|February 16, 2020
Somatostatin Analogs Improve Respiratory Symptoms in Patients With Diffuse Idiopathic Neuroendocrine Cell HyperplasiaTaymeyah Al-Toubah, Jonathan Strosberg, Thorvardur R Halfdanarson, et al.
European Journal of Endocrinology|July 30, 2008
Long-acting somatostatin analogues are an effective treatment for type 1 gastric carcinoid tumoursSimona Grozinsky-Glasberg, Gregory Kaltsas, Chamutal Gur, et al.
Academic Pathology|October 17, 2022
Features of burnout amongst pathologists: A reassessmentMichael B Cohen, Marisa Saint Martin, David J Gross, et al.
The Journal of Heart Valve Disease|December 19, 2016
Valve Replacement in Patients with Carcinoid Heart Disease: Choosing the Right Valve at the Right TimeAmit Korach, Simona Grozinsky-Glasberg, Joseph Atlan, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|May 12, 2020
The prognostic value of lymph node ratio in Medullary thyroid carcinoma: A multi-center studyTal Rozenblat, Dania Hirsch, Eyal Robenshtok, et al.
European Journal of Nuclear Medicine and Molecular Imaging|October 22, 2018
Highly favourable outcomes with peptide receptor radionuclide therapy (PRRT) for metastatic rectal neuroendocrine neoplasia (NEN)Grace Kong, Simona Grozinsky-Glasberg, Michael S Hofman, et al.
Archives of Pathology & Laboratory Medicine|July 1, 2022
Strong Job Market for Pathologists: Results From the 2021 College of American Pathologists Practice Leader SurveyDavid J Gross, Stanley J Robboy, Michael B Cohen, et al.
Clinical Nuclear Medicine|December 14, 2011
Ga-68 DOTA-NOC uptake in the pancreas: pathological and physiological patternsYodphat Krausz, Rina Rubinstein, Liat Appelbaum, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 29, 2021
Efficacy and Safety of <sup>177</sup>Lu-DOTATATE in Lung Neuroendocrine Tumors: A Bicenter studyLamiaa Zidan, Amir Iravani, Kira Oleinikov, et al.
Endocrine-Related Cancer|September 21, 2005
Etoposide, doxorubicin and cisplatin plus mitotane in the treatment of advanced adrenocortical carcinoma: a large prospective phase II trialAlfredo Berruti, Massimo Terzolo, Paola Sperone, et al.
Pageof 8